Customer Stories

Synchrogistics, a leading third-party logistics firm, was founded in 2010 with the goal of combining high-level data analytics with expert consulting. Fueled by a strong desire to improve shipment visibility, they needed a reliable way to track shipments—one that was in their control, as opposed to solutions where they could only rely on what drivers reported back to them.

Founded in 1908, Lamaignere is a global freight transportation company with a presence in more than a dozen countries. Because Lamaignere handles sensitive, high-value goods subject to specific environmental parameters, the company deemed it necessary to obtain real-time visibility over its shipment—and they turned to Tive

Potomac Metals—a privately-held, independent scrap metal recycling company—was founded in 1996 in Sterling, Virginia, and offers a variety of services to their commercial, residential, and industrial customers. Prior to Tive, the company was at the mercy of their brokers and dispatchers. Potomac Metals lacked real-time insight into the location and condition of their shipments, and spent hours manually tracking their expensive cargo.

Founded in 1972, Vianney is a Mexico-based company specializing in the manufacturing and sale of blankets, bedspreads, comforters, sheets, curtains, and home décor items. Vianney needed a reliable way to track their shipments, to protect its clients—and their businesses—from the risks associated with the cartel and criminal organizations... and found Tive.‍

Founded in 2006, YSDS is an international logistics company specializing in unique, customized logistics solutions. Headquartered in Stockholm, Sweden with 11 offices worldwide—and focused on life sciences, IT, and Emergency Part Logistics—YSDS has more than 150 qualified partners and successfully conducts over 80,000 shipments annually.

Powered by groundbreaking cell and gene therapy technology, this innovative Boston life sciences company is committed to delivering a new class of differentiated, one-time curative genetic therapies to address a wide spectrum of diseases—providing precise and effective medicines for patients throughout the United States.